Regent Peak Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$534K Sell
1,065
-15
-1% -$7.2K 0.1% 91
2026
Q1
$531K Sell
1,080
-225
-17% -$122K 0.11% 84
2025
Q4
$756K Sell
1,305
-13
-1% -$7.35K 0.15% 58
2025
Q3
$639K Buy
+1,318
New +$613K 0.13% 72
2025
Q1
$665K Sell
1,337
-35
-3% -$19K 0.16% 66
2024
Q4
$714K Sell
1,372
-11
-0.8% -$6.05K 0.16% 66
2024
Q3
$855K Sell
1,383
-43
-3% -$25.5K 0.2% 67
2024
Q2
$788K Buy
1,426
+23
+2% +$13.2K 0.18% 71
2024
Q1
$815K Buy
1,403
+49
+4% +$27.5K 0.21% 67
2023
Q4
$719K Sell
1,354
-99
-7% -$47.9K 0.2% 67
2023
Q3
$735K Buy
1,453
+15
+1% +$7.99K 0.22% 66
2023
Q2
$750K Sell
1,438
-1
-0.1% -$540 0.22% 66
2023
Q1
$829K Sell
1,439
-72
-5% -$40.6K 0.26% 57
2022
Q4
$833K Sell
1,511
-7
-0.5% -$3.71K 0.27% 62
2022
Q3
$770K Buy
1,518
+24
+2% +$13.4K 0.27% 66
2022
Q2
$811K Buy
1,494
+26
+2% +$14.3K 0.27% 61
2022
Q1
$867K Sell
1,468
-45
-3% -$25.9K 0.25% 58
2021
Q4
$1.01M Buy
1,513
+61
+4% +$38.1K 0.27% 56
2021
Q3
$830K Buy
1,452
+14
+1% +$7.68K 0.24% 65
2021
Q2
$777K Sell
1,438
-9
-0.6% -$4.25K 0.22% 69
2021
Q1
$660K Sell
1,447
-17
-1% -$8.11K 0.22% 73
2020
Q4
$682K Buy
1,464
+275
+23% +$129K 0.23% 70
2020
Q3
$525K Buy
1,189
+136
+13% +$56.2K 0.22% 68
2020
Q2
$382K Buy
1,053
+181
+21% +$60.7K 0.17% 78
2020
Q1
$247K Buy
872
+52
+6% +$16.4K 0.14% 94
2019
Q4
$266K Buy
+820
New +$249K 0.12% 104

Other funds holding TMO

Regent Peak Wealth Advisors's TMO Position: Q2 2026 in Review

Regent Peak Wealth Advisors reduced its Thermo Fisher Scientific (TMO) stake by 1.4% in Q2 2026, selling an estimated $7.2K and leaving 1,065 shares worth $534K. The position accounts for 0.1% of the portfolio, ranked #91.

Regent Peak Wealth Advisors first reported a position in TMO in Q4 2019 and has held it in 26 quarters since. The position peaked at $1.01M in Q4 2021. 500 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Regent Peak Wealth Advisors held 1,065 shares of Thermo Fisher Scientific worth $534K as of Q2 2026.
  • Regent Peak Wealth Advisors sold 15 Thermo Fisher Scientific shares in Q2 2026, an estimated $7.2K.
  • Thermo Fisher Scientific made up 0.1% of Regent Peak Wealth Advisors's portfolio in Q2 2026, its #91 holding.
  • Regent Peak Wealth Advisors first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 26 quarters since.
  • Regent Peak Wealth Advisors's Thermo Fisher Scientific position peaked at $1.01M in Q4 2021.
  • 500 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Regent Peak Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.